Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
Irena Kaplanov, Yaron Carmi, Rachel Kornetsky, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 116, Iss. 4, pp. 1361-1369
Open Access | Times Cited: 371

Showing 1-25 of 371 citing articles:

Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1113
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Alberto Mantovani, Charles A. Dinarello, Martina Molgora, et al.
Immunity (2019) Vol. 50, Iss. 4, pp. 778-795
Open Access | Times Cited: 839
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
Emma Morris, Sattva S. Neelapu, Theodoros Giavridis, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 2, pp. 85-96
Open Access | Times Cited: 616
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 261
IL-1 Family Members in Cancer; Two Sides to Every Story
Kevin James Baker, Aileen Houston, Elizabeth Brint
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 244
Interleukin-1β and Cancer
Cédric Rébé, François Ghiringhelli
Cancers (2020) Vol. 12, Iss. 7, pp. 1791-1791
Open Access | Times Cited: 229
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Defne Bayık, Yadi Zhou, Chihyun Park, et al.
Cancer Discovery (2020) Vol. 10, Iss. 8, pp. 1210-1225
Open Access | Times Cited: 185
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
Shaima’a Hamarsheh, Robert Zeiser
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 184
Pyroptosis, a new bridge to tumor immunity
Lisha Li, Mingxia Jiang, Ling Qi, et al.
Cancer Science (2021) Vol. 112, Iss. 10, pp. 3979-3994
Open Access | Times Cited: 153
Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs
Maren Pein, Jacob Insua‐Rodríguez, Tsunaki Hongu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 147
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion
Isak W. Tengesdal, Dinoop Ravindran Menon, Douglas G. Osborne, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 10
Open Access | Times Cited: 139
Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth
R. K. Subbarao Malireddi, Rajendra Karki, Balamurugan Sundaram, et al.
ImmunoHorizons (2021) Vol. 5, Iss. 7, pp. 568-580
Open Access | Times Cited: 136
NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
Sara Socorro Faria, Susan Costantini, Vladmir Cláudio Cordeiro de Lima, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 123
CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment
Jiakang Jin, Jinti Lin, Ankai Xu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 120
CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy
Mahrukh Huseni, Lifen Wang, Joanna E. Klementowicz, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 1, pp. 100878-100878
Open Access | Times Cited: 112
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Ola Habanjar, Rea Bingula, Caroline Decombat, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4002-4002
Open Access | Times Cited: 112
The Role of Inflammation in CKD
Saurav Prashant Kadatane, Matthew Satariano, M. Massey, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1581-1581
Open Access | Times Cited: 110
Rethinking immune checkpoint blockade: ‘Beyond the T cell’
Xiuting Liu, Graham D. Hogg, David G. DeNardo
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001460-e001460
Open Access | Times Cited: 108
The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma
Weichen Wang, Zhichao Lu, Maoyu Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 85
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis
Zheng Gong, Qing Li, Jiayuan Shi, et al.
Science Immunology (2023) Vol. 8, Iss. 80
Open Access | Times Cited: 63
IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance
Yi Han, Yanyu Zhang, Yi‐Qian Pan, et al.
Molecular Cell (2023) Vol. 83, Iss. 11, pp. 1887-1902.e8
Open Access | Times Cited: 52
Targeting inflammation as cancer therapy
Manni Wang, Siyuan Chen, Xuemei He, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 32
SLC7A11-ROS/αKG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression
Tingting Lv, Xiude Fan, Chang He, et al.
Redox Biology (2024) Vol. 72, pp. 103159-103159
Open Access | Times Cited: 17
The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications
Ting Ding, Chang Liu, Zhengyu Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top